SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70

被引：0
|
作者：
He-wei Jiang
Hai-nan Zhang
Qing-feng Meng
Jia Xie
Yang Li
Hong Chen
Yun-xiao Zheng
Xue-ning Wang
Huan Qi
Jing Zhang
Pei-Hui Wang
Ze-Guang Han
Sheng-ce Tao
机构：
[1] Shanghai Jiao Tong University,Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education)
[2] Shandong University,Advanced Medical Research Institute
来源：
Cellular & Molecular Immunology | 2020年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：998 / 1000
页数：2
相关论文
共 50 条
  • [21] The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING
    Cao, Dan
    Duan, Lian
    Huang, Bin
    Xiong, Yuxian
    Zhang, Guoliang
    Huang, Hao
    SCIENCE SIGNALING, 2023, 16 (783)
  • [22] Structural characterization of SARS-CoV-2 dimeric ORF9b reveals potential fold-switching trigger mechanism
    Xiyue Jin
    Xue Sun
    Yan Chai
    Yu Bai
    Ying Li
    Tianjiao Hao
    Jianxun Qi
    Hao Song
    Catherine CL Wong
    George F.Gao
    Science China(Life Sciences), 2023, 66 (01) : 152 - 164
  • [23] Evasion of Type I Interferon by SARS-CoV-2
    Xia, Hongjie
    Cao, Zengguo
    Xie, Xuping
    Zhang, Xianwen
    Chen, John Yun-Chung
    Wang, Hualei
    Menachery, Vineet D.
    Rajsbaum, Ricardo
    Shi, Pei-Yong
    CELL REPORTS, 2020, 33 (01):
  • [24] Structural characterization of SARS-CoV-2 dimeric ORF9b reveals potential fold-switching trigger mechanism
    Xiyue Jin
    Xue Sun
    Yan Chai
    Yu Bai
    Ying Li
    Tianjiao Hao
    Jianxun Qi
    Hao Song
    Catherine C. L. Wong
    George F. Gao
    Science China Life Sciences, 2023, 66 : 152 - 164
  • [25] A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication
    Zhou, Yuzheng
    Chen, Zongpeng
    Liu, Sijie
    Liu, Sixu
    Liao, Yujie
    Du, Ashuai
    Dong, Zijun
    Zhang, Yongxing
    Chen, Xuan
    Tao, Siyi
    Wu, Xin
    Razzaq, Aroona
    Xu, Gang
    Tan, De-an
    Li, Shanni
    Deng, Youwen
    Peng, Jian
    Dai, Shuyan
    Deng, Xu
    Zhang, Xianwen
    Jiang, Taijiao
    Zhang, Zheng
    Cheng, Gong
    Zhao, Jincun
    Xia, Zanxian
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [26] Structural characterization of SARS-CoV-2 dimeric ORF9b reveals potential fold-switching trigger mechanism
    Jin, Xiyue
    Sun, Xue
    Chai, Yan
    Bai, Yu
    Li, Ying
    Hao, Tianjiao
    Qi, Jianxun
    Song, Hao
    Wong, Catherine C. L.
    Gao, George F.
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (01) : 152 - 164
  • [27] SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO
    Wu, Jing
    Shi, Yuheng
    Pan, Xiaoyan
    Wu, Shuang
    Hou, Ruixia
    Zhang, Yong
    Zhong, Tiansheng
    Tang, Hao
    Du, Wei
    Wang, Luying
    Wo, Jing
    Mu, Jingfang
    Qiu, Yang
    Yang, Ke
    Zhang, Lei-Ke
    Ye, Bang-Ce
    Qi, Nan
    CELL REPORTS, 2021, 34 (07):
  • [28] Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
    Lokugamage, Kumari G.
    Hage, Adam
    de Vries, Maren
    Valero-Jimenez, Ana M.
    Schindewolf, Craig
    Dittmann, Meike
    Rajsbaum, Ricardo
    Menachery, Vineet D.
    JOURNAL OF VIROLOGY, 2020, 94 (23)
  • [29] Characterization of SARS-CoV-2 omicron variants from Iran and evaluation of the effect of mutations on the spike, nucleocapsid, ORF8, and ORF9b proteins function
    Ahmadi, Khadijeh
    Shahbazi, Behzad
    Zakeri, Abdul-Jabbar
    Gouklani, Hamed
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (21): : 11415 - 11430
  • [30] The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
    Li, Jin-Yan
    Liao, Ce-Heng
    Wang, Qiong
    Tan, Yong-Jun
    Luo, Rui
    Qiu, Ye
    Ge, Xing-Yi
    VIRUS RESEARCH, 2020, 286
12345